AHMED NADIM - Insider Non-Derivative Transactions at Cullinan Oncology, Inc. (CGEM) - (SEC)
Updated on December 12, 2024.
According to recent SEC insider information filed on Feb 22, 2024, AHMED NADIM's relationship to Cullinan Oncology, Inc. (CGEM) is Director,Officer (President and CEO), and currently has 271,550 shares of Common Stock.
The chart below shows the number of shares owned, and the table shows the recent insider transactions.
You can see similar information for other CGEM insiders.
Data Source: SEC.
AHMED NADIM - Insider Non-Derivative Transactions of CGEM Common Stock
AHMED NADIM - Insider Non-Derivative Transactions at CGEM
Items per page:
0 of 0
| Date | Transaction | No. of Shares | Price Per Share | Shares Owned After Transactions |
|---|---|---|---|---|
| Feb 23, 2024 | Acquisition -- (Common Stock) | 160000 | 0 | 271550 |
| Dec 27, 2023 | Sell -- (Common Stock) | 4272 | 9.24 | 111550 |
| Jun 29, 2023 | Sell -- (Common Stock) | 759 | 11.4 | 115822 |
| May 24, 2023 | Sell -- (Common Stock) | 707 | 9.15 | 116581 |
| Apr 26, 2023 | Sell -- (Common Stock) | 716 | 10.59 | 117288 |
| Mar 24, 2023 | Sell -- (Common Stock) | 706 | 10.51 | 118004 |
| Feb 23, 2023 | Acquisition -- (Common Stock) | 109000 | 0 | 118710 |